sulfanilamide   Click here for help

GtoPdb Ligand ID: 12631

Synonyms: AVC® | sulphanilamide
Approved drug PDB Ligand
sulfanilamide is an approved drug (FDA (1965))
Compound class: Synthetic organic
Comment: Sulfanilamide is sulfonamide antimicrobial compound. It was first synthesized in 1908, but it was not until the 1930s that its antibacterial activity was discovered [3-4].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 1
Topological polar surface area 94.56
Molecular weight 172.21
XLogP -1.26
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=C(C=CC(=C1)S(=O)(=O)N)N
Isomeric SMILES C1=CC(=CC=C1N)S(=O)(=O)N
InChI InChI=1S/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)
InChI Key FDDDEECHVMSUSB-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Sulfanilamide is used as a topical formulation to treat vulvovaginitis caused by Candida albicans. It was marketed in the US (under the trade name AVC®:) but has been discontinued. The drug is not approved by the EMA, but individual European agencies have authorised its use.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Sulfonamides are structural analogues of 4-aminobenzoic acid (pABA) an intermediate in the de novo synthesis of folate by some prokaryotes, lower eukaryotes and plants [2]. The antibacterial MMOA is competitive inhibition of bacterial dihydropteroate synthase (DHPS) resulting in a block of folate biosynthesis [1].
External links Click here for help